Coverage
Danish medical device maker Coloplast on Tuesday reported 7% organic revenue growth for its 2024/25 fiscal year, meeting its targets as it navigates a period of strategic and leadership transition.
Danish medical device maker Coloplast on Tuesday reported 7% organic revenue growth for its 2024/25 fiscal year, meeting its targets, and forecast a similar performance for the year ahead as it implements a new strategy.
Coloplast interim Chief Executive Lars Rasmussen will step down from the company's board of directors, the latest leadership change at the Danish medical device maker as it implements a new strategy.
Danish medical device maker Coloplast on Tuesday unveiled a new five-year strategy that tempers its long-term growth forecast.
Danish medical device maker Coloplast on Tuesday tempered its long-term growth forecast as it unveiled a new five-year strategy, dubbed "Impact4."
Danish medical device maker Coloplast announced a significant overhaul of its executive team and corporate structure on Tuesday, moves it said are designed to support a new long-term strategy.
Filings
| Filing | Date |
|---|---|
| Coloplast, Financial Statement 2002/03 | 18 Nov 2003 |
| Coloplast, annual report 2002/03 | 18 Nov 2003 |
| Coloplast, 2002/03 Annual Report and Annual General Meeting | 30 Oct 2003 |
| InvestorService: Coloplast, New General Manager at Coloplast | 17 Oct 2003 |
| Coloplast, financial Calendar 2003/04 | 16 Oct 2003 |
| Coloplast, quarterly statement of shareholdings | 19 Sept 2003 |
| Coloplast, current statement of shareholdings | 5 Sept 2003 |
| Coloplast, current statement of shareholdings | 28 Aug 2003 |
| Coloplast, current statement of shareholdings | 26 Aug 2003 |
| Coloplast, quarterly report Q3 2002/03 | 21 Aug 2003 |
| Coloplast, issue of financial statement for Q3 rescheduled | 20 Jun 2003 |
| Coloplast, quarterly statement of shareholdings as of 13 June 2003 | 13 Jun 2003 |